ARTL

ARTL

USD

Artelo Biosciences Inc. Common Stock

$15.900-0.480 (-2.930%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$16.380

High

$19.000

Low

$14.618

Volume

0.50M

Company Fundamentals

Market Cap

8.7M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.67M

Exchange

NCM

Currency

USD

52-Week Range

Low $4.92Current $15.900High $25.58

Related News

Analyst Upgrades

D. Boral Capital Upgrades Artelo Biosciences to Buy, Announces $20 Price Target

D. Boral Capital analyst Jason Kolbert upgrades Artelo Biosciences from Hold to Buy and announces $20 price target.

View more
D. Boral Capital Upgrades Artelo Biosciences to Buy, Announces $20 Price Target
GlobeNewswire

Artelo Biosciences Announces Positive Preclinical Efficacy with ART12.11 in Stress-Induced Depression Model

ART12.11, the Patented CBD:TMP Cocrystal, Demonstrates Potent Antidepressant-Like Activity and Cognitive Benefits Over Leading SSRI Data Being Presented at the 35th Annual International Cannabinoid Research Society

View more
Artelo Biosciences Announces Positive Preclinical Efficacy with ART12.11 in Stress-Induced Depression Model
GlobeNewswire

Artelo Biosciences Announces Positive First-in-Human Data for ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent Pain

First Orally Active Fatty Acid Binding Protein 5 Inhibitor Evaluated in Humans First-in-Class Approach Targets Unmet Need in Multibillion-Dollar Pain Management Market SOLANA BEACH, Calif., June 30, 2025 (GLOBE

View more
Artelo Biosciences Announces Positive First-in-Human Data for ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent Pain